Clinical Trials Browser

Phase 3 × Has results × Peripheral Nervous System Diseases × Clear all

Neoplasms, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT00369564 2021-08-11

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

GenitourinaryLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Kidney Neoplasms, Leukemia, Lymphoma, Wilms Tumor, Peripheral Nervous System Diseases, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Dendritic Cell Sarcoma, Interdigitating

NCT00195013 2018-06-06

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

Phase 3 Completed

30 enrolled 5 charts

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT00471445 2015-11-09

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

Phase 3 Completed

462 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Clinical Trials

POLAR-A

Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer

Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients